CSIMarket Company Name, Ticker, Industry, else..
 
Peak Bio Inc   (NONE: PKBO)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 28
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -3
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Business Description


Peak Bio Inc is a biotechnology company that focuses on developing innovative therapeutic solutions for various medical conditions. The company is driven by a mission to improve global health outcomes and enhance quality of life for patients through cutting-edge research and development efforts. Their pipeline includes a range of novel drug candidates targeting cancer, neurodegenerative disorders, and rare diseases, among others. Peak Bio Inc is known for its interdisciplinary approach, combining expertise in biology, chemistry, and pharmacology to provide effective and safe treatments. With a strong commitment to scientific excellence, the company has gained recognition within the biotech industry and has established strategic collaborations with leading academic institutions and pharmaceutical companies.


   Company Address: 4900 Hopyard Road., Suite 100 Pleasanton 94588 CA
   Company Phone Number: 463-4800   Stock Exchange / Ticker: NONE PKBO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AMGN        6.21% 
BIIB        3.89% 
EXEL   -0.89%    
GILD   -1.29%    
HALO        1.65% 
MRNA        27.09% 
• View Complete Report
   



Merger and Acquisition

Revolutionizing Targeted Therapeutics: Akari Therapeutics and Peak Bio Unveil Portfolio Prioritization Plan for Post-Merger Entity

Published Wed, May 1 2024 12:01 PM UTC

Akari Therapeutics and Peak Bio Join Forces in Strategic Merger, Prioritizing ADC Technology and GA Program
BOSTON and PLEASANTON, Calif., May 01, 2024 - Akari Therapeutics, Plc (Nasdaq: AKTX, Akari) and Peak Bio Inc. (OTC: PKBO, Peak) have recently announced the successful completion of a joint portfolio prioritization review. This marks a significant milestone in their...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.04
Working Capital Ratio 0.07
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.16 $
Revenues (TTM) 0 $
Cash Flow (TTM) 0.03 $
Cash 0.03 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.